Showing 1 – 12 of 12
SORT: Best Match Most Recent Oldest
VIEW: Basic | Expanded
  • JAMA Patient Page November 18, 2009

    Janet M. Torpy, MD; Alison E. Burke, MA; Richard M. Glass, MD
    TOPICS: nf1 gene, neurofibromatoses

    JAMA. 2009; 302(19):2170-2170. doi: 10.1001/jama.302.19.2170

    Includes: Supplemental Content
  • JAMA Patient Page July 16, 2008

    Janet M. Torpy, MD; Alison E. Burke, MA; Richard M. Glass, MD
    TOPICS: nf1 gene, neurofibromatoses

    JAMA. 2008; 300(3):352-352. doi: 10.1001/jama.300.3.352

    Includes: Supplemental Content
  • Original Contribution November 18, 2009

    Ludwine Messiaen, PhD; Suxia Yao, MD; Hilde Brems, MS; Tom Callens, BSc; Achara Sathienkijkanchai, MD; Ellen Denayer, MD; Emily Spencer, BSc; Pamela Arn, MD; Dusica Babovic-Vuksanovic, MD; Carolyn Bay, MD; Gary Bobele, MD; Bruce H. Cohen, MD; Luis Escobar, MD; Deborah Eunpu, MS; Theresa Grebe, MD; Robert Greenstein, MD; Rachel Hachen, MD; Mira Irons, MD; David Kronn, MD; Edmond Lemire, MD, PhD; Kathleen Leppig, MD; Cynthia Lim, MS; Marie McDonald, MD; Vinodh Narayanan, MD; Amy Pearn, MS; Robert Pedersen, MD; Berkley Powell, MD; Lawrence R. Shapiro, MD; David Skidmore, MD; David Tegay, DO; Heidi Thiese, MS; Elaine H. Zackai, MD; Raymon Vijzelaar, MSc; Koji Taniguchi, MD, PhD; Toranoshin Ayada, MD, PhD; Fuyuki Okamoto, BSc; Akihiko Yoshimura, PhD; Annabel Parret, PhD; Bruce Korf, MD, PhD; Eric Legius, MD, PhD
    TOPICS: mutation, glioma, missense mutation, neurofibromatoses, neurofibromatosis 1, freckles, spred-1 protein

    JAMA. 2009; 302(19):2111-2118. doi: 10.1001/jama.2009.1663

    Includes: Supplemental Content
  • Original Contribution December 15, 2010

    Li Yao, PhD; Francesca Schiavi, MD, PhD; Alberto Cascon, PhD; Yuejuan Qin, MD, PhD; Lucia Inglada-Pérez, PhD; Elizabeth E. King, MD; Rodrigo A. Toledo, PhD; Tonino Ercolino, PhD; Elena Rapizzi, PhD; Christopher J. Ricketts, PhD; Luigi Mori, PhD; Mara Giacchè, PhD; Antonella Mendola, PhD; Elisa Taschin, PhD; Francesca Boaretto, PhD; Paola Loli, MD; Maurizio Iacobone, MD; Gian-Paolo Rossi, MD; Bernadette Biondi, MD; José Viana Lima-Junior, MD; Claudio E. Kater, MD; Marie Bex, MD; Miikka Vikkula, PhD; Ashley B. Grossman, MD; Stephen B. Gruber, MD; Marta Barontini, MD; Alexandre Persu, MD; Maurizio Castellano, MD; Sergio P. A. Toledo, MD; Eamonn R. Maher, MD, FMedSci; Massimo Mannelli, MD; Giuseppe Opocher, MD; Mercedes Robledo, PhD; Patricia L. M. Dahia, MD, PhD
    TOPICS: pheochromocytoma, polymerase chain reaction, mutation, genes, paraganglioma, neoplasms

    JAMA. 2010; 304(23):2611-2619. doi: 10.1001/jama.2010.1830

    Includes: Supplemental Content
  • Original Investigation September 01, 2015

    Rajen J. Mody, MBBS, MS; Yi-Mi Wu, PhD; Robert J. Lonigro, MS; Xuhong Cao, MS; Sameek Roychowdhury, MD, PhD; Pankaj Vats, MS; Kevin M. Frank, MS; John R. Prensner, MD, PhD; Irfan Asangani, PhD; Nallasivam Palanisamy, PhD; Jonathan R. Dillman, MD; Raja M. Rabah, MD; Laxmi Priya Kunju, MD; Jessica Everett, MS; Victoria M. Raymond, MS; Yu Ning, MS; Fengyun Su, PhD; Rui Wang, MS; Elena M. Stoffel, MD; Jeffrey W. Innis, MD, PhD; J. Scott Roberts, PhD; Patricia L. Robertson, MD; Gregory Yanik, MD; Aghiad Chamdin, MD; James A. Connelly, MD; Sung Choi, MD; Andrew C. Harris, MD; Carrie Kitko, MD; Rama Jasty Rao, MD; John E. Levine, MD; Valerie P. Castle, MD; Raymond J. Hutchinson, MD; Moshe Talpaz, MD; Dan R. Robinson, PhD; Arul M. Chinnaiyan, MD, PhD
    TOPICS: cancer, child

    JAMA. 2015; 314(9):913-925. doi: 10.1001/jama.2015.10080

    Includes: Supplemental Content
  • Preliminary Communication August 25, 2015

    Jeffery M. Klco, MD, PhD; Christopher A. Miller, PhD; Malachi Griffith, PhD; Allegra Petti, PhD; David H. Spencer, MD, PhD; Shamika Ketkar-Kulkarni, MS; Lukas D. Wartman, MD; Matthew Christopher, MD, PhD; Tamara L. Lamprecht, BS; Nicole M. Helton, BS; Eric J. Duncavage, MD; Jacqueline E. Payton, MD, PhD; Jack Baty, BA; Sharon E. Heath; Obi L. Griffith, PhD; Dong Shen, PhD; Jasreet Hundal, MS; Gue Su Chang, PhD; Robert Fulton, MS; Michelle O'Laughlin, BS; Catrina Fronick, BS; Vincent Magrini, PhD; Ryan T. Demeter, BE; David E. Larson, PhD; Shashikant Kulkarni, MS, PhD; Bradley A. Ozenberger, PhD; John S. Welch, MD, PhD; Matthew J. Walter, MD; Timothy A. Graubert, MD; Peter Westervelt, MD, PhD; Jerald P. Radich, MD; Daniel C. Link, MD; Elaine R. Mardis, PhD; John F. DiPersio, MD, PhD; Richard K. Wilson, PhD; Timothy J. Ley, MD
    TOPICS: leukemia, myelocytic, acute, mutation, chemotherapy regimen, disease remission

    JAMA. 2015; 314(8):811-822. doi: 10.1001/jama.2015.9643

    Includes: CME, Supplemental Content
  • Original Investigation June 18, 2014

    Richard D. Carvajal, MD; Jeffrey A. Sosman, MD; Jorge Fernando Quevedo, MD; Mohammed M. Milhem, MD; Anthony M. Joshua, MBBS, PhD; Ragini R. Kudchadkar, MD; Gerald P. Linette, MD, PhD; Thomas F. Gajewski, MD, PhD; Jose Lutzky, MD; David H. Lawson, MD; Christopher D. Lao, MD; Patrick J. Flynn, MD; Mark R. Albertini, MD; Takami Sato, MD, PhD; Karl Lewis, MD; Austin Doyle, MD; Kristin Ancell, MD; Katherine S. Panageas, DrPH; Mark Bluth, MD; Cyrus Hedvat, MD, PhD; Joseph Erinjeri, MD, PhD; Grazia Ambrosini, PhD; Brian Marr, MD; David H. Abramson, MD; Mark Andrew Dickson, MD; Jedd D. Wolchok, MD, PhD; Paul B. Chapman, MD; Gary K. Schwartz, MD
    TOPICS: chemotherapy regimen, therapeutics, intraocular melanoma, selumetinib, progression-free survival

    JAMA. 2014; 311(23):2397-2405. doi: 10.1001/jama.2014.6096

    Includes: Supplemental Content